Puma Shares Plunge, Bulls Flee as Cancer Patients Stop Drug

(Bloomberg) -- Shares of Puma Biotechnology Inc. sank as much as 41 percent Friday -- on pace for their lowest close in more than six years -- after first quarter earnings revealed that more patien...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.